RobertCKalayjianMD
Infectious Disease • Cleveland, OHAssociate Professor, Medicine, Case Western Reserve University School of Medicine
Dr. Kalayjian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2500 Metrohealth Dr
Cleveland, OH 44109Phone+1 216-778-7800
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Infectious Disease, 1988 - 1990- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1982 - 1985
Tufts University School of MedicineClass of 1982
Certifications & Licensure
OH State Medical License 1988 - 2026
TN State Medical License 1985 - 1988- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)
- The Effects of Prednisone on HIV Levels and the Immune System Start of enrollment: 1996 Aug 01
- A Study of HIV-Disease Development in Aging Start of enrollment: 2000 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 89 citationsPrednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathyMichael C. Smith, Jeffrey L. Austen, John T. Carey, Steven N. Emancipator, Thomas E. Herbener
The American Journal of Medicine. 1996-07-01 - 253 citationsThe clinical epidemiology and course of the spectrum of renal diseases associated with HIV infectionLynda A. Szczech, Samir K. Gupta, Ramez Habash, Antonio Guasch, Robert C. Kalayjian
Kidney International. 2004-09-01 - 99 citationsRisk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine careRobert C. Kalayjian, Bryan Lau, Rhoderick N. Mechekano, Heidi M. Crane, Benigno Rodriguez
AIDS. 2012-09-24
Journal Articles
- The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults with Human Immunodeficiency Virus...C William Wester, Edgar Turner Overton, Susan L Koletar, Kristine M Erlandson, Constance A Benson, Robert C Kalayjian, Clinical Infectious Diseases
Press Mentions
Why Humans Are Making Epidemics WorseMarch 29th, 2016
Grant Support
- ACTG A5146: Therapeutic Drug Monitoring On Viral Load, Pi-Experienced HIV-1 PTSNational Center For Research Resources2006
- A5223: Sex Differences In Lpv/Rtv In HIV Infected Men And WomenNational Center For Research Resources2006
- A5214: SQ Single Dose Interleukin-7 In HIV-1 Infected SubjectsNational Center For Research Resources2006
- A5163: Weekly Alendronate In HIV Subjects With Decreased Bone Mineral DensityNational Center For Research Resources2006
- A5142:Comparison Of Treatment For Initial Therapy Of HIV InfectionNational Center For Research Resources2006
- A5211: An Orally Administered HIV-1 Entry Inhibitor In HIV Tx Experienced PTSNational Center For Research Resources2005–2006
- ACTG A5177:Pharmacokinetics Of Efavirenz, Nevirapine, Lopinavir/Ritonavir In HIVNational Center For Research Resources2005
- ACTG A5163:Qweek Alendronate In HIV Subjects With Decreased Bone Mineral DensityNational Center For Research Resources2005
- ACTG A5142:Comparison Of Treatment For Initial Therapy Of HIV InfectionNational Center For Research Resources2005
- ACTG A5163: Weekly Alendronate In HIV Subjs With Decreased Bone Mineral DensityNational Center For Research Resources2004
- ACTG A5148: Niacin For Treatment Of Elevated Non-Hdl Cholesterol In HIVNational Center For Research Resources2004
- ACTG A5143/A5147s: Dual VS Triple PI Combinations For Treatment Failures In HIV1National Center For Research Resources2004
- ACTG A5142-Comparison Of Treatment For Initial Therapy Of HIV InfectionNational Center For Research Resources2004
- ACTG A5110-Thymidine Analogue Substitution Or Nucleoside-Sparing RegimenNational Center For Research Resources2004
- ACTG 384--Protease /Reverse Transcriptase Inhib In HIVNational Center For Research Resources2000–2002
- ACTG 349--Immunologic &Virologic Effects Of Prednisone On HIV-1 InfectionNational Center For Research Resources2000–2002
- Abt378/Ritonavir/Stavudine/Lamivudine/Nelfinavir In HIV InfectionNational Center For Research Resources2000–2002
- Abt378/Ritonavir In Combination With Other Drugs In HIV InfectionNational Center For Research Resources2000–2002
- Antituberculosis Agents In HIV Infected Persons W/ TBNational Center For Research Resources1999–2002
- Viral Activation Transfusion Study (VATS)National Center For Research Resources1997–2002
- ACTG 372:Prolongation Of Virologic Success &Options For Failure In HNational Center For Research Resources1999–2000
- ACTG 370:Virologic &Immunologic Activity Of Continued Lamivudine VSNational Center For Research Resources1999–2000
- ACTG 359:Soft Gelatin Capsule Of Saquinavir W/ Ritonavir Or NelfinaviNational Center For Research Resources1999–2000
- ACTG 271--Prednisone Therapy In HIV Associated NephropathyNational Center For Research Resources1996–1997
- Foscarnet Cream For The Treatment Of Mucotaneous Herpes SimplexNational Center For Research Resources1996
- Foscarnet Cream For The Treatment Of Mucocutaneous Herpes SimplexNational Center For Research Resources1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
